Virtual Development of COVID-19 Drugs Targeting Nsp16-Nsp10 Complex
DOI:
https://doi.org/10.47611/jsrhs.v12i2.4368Keywords:
SARS-CoV-2, COVID-19, Nsp-Nsp10 Complex, SARS-CoV-2 Nsp16Abstract
The search for pharmaceutical treatment for COVID-19 has been progressive. Currently approved medicines include therapeutic antibodies and antiviral drugs. However, the effectiveness of current antiviral drugs is far from satisfactory, which suggests the necessity for improvement. In this research, we selected the non-structural protein complex Nsp16-Nsp10, which is responsible for methylating SARS-CoV-2’s RNA, as a drug target. With computer-aided drug development technology, we screened two potential drugs either by inhibiting the SAM catalytic pocket on the complex or inhibiting the binding between Nsp16 and Nsp10 from preventing the Nsp16-Nsp10 complex helping SARS-CoV-2 duplicate, and that will work in COVID-19 treatment.
Downloads
References or Bibliography
Chen, Y., Su, C., Ke, M., Jin, X., Xu, L., Zhang, Z., Wu, A., Sun, Y., Yang, Z., Tien, P., Ahola, T., Liang, Y., Liu,
X., & Guo, D. (2011). Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2’-O-methylation by nsp16/nsp10 protein complex. PLoS Pathogens, 7(10), e1002294.
https://doi.org/10.1371/journal.ppat.1002294
Gorkhali, R., Koirala, P., Rijal, S., Mainali, A., Baral, A., & Bhattarai, H. K. (2021). Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins. Bioinformatics and Biology Insights, 15, 117793222110258.
https://doi.org/10.1177/11779322211025876
Griesel, M., Wagner, C., Mikolajewska, A., Stegemann, M., Fichtner, F., Metzendorf, M.-I., Nair, A. A., Daniel,
J.,Fischer, A.-L., & Skoetz, N. (2022). Inhaled corticosteroids for the treatment of COVID-19. Cochrane Database of Systematic Reviews, 2022(3).
https://doi.org/10.1002/14651858.cd015125
Minasov, G., Rosas-Lemus, M., Shuvalova, L., Inniss, N. L., Brunzelle, J. S., Daczkowski, C. M., Hoover, P., Mesecar, A. D., & Satchell, K. J. F. (2021). Mn2+ coordinates Cap-0-RNA to align substrates for efficient 2′-O-methyl transfer by SARS-CoV-2 nsp16. Science Signaling, 14(689), eabh2071. https://doi.org/10.1126/scisignal.abh2071
Mulia, E. P. B., & Luke, K. (2021). Inhaled prostacyclin analogues in COVID-19 associated acute respiratory
distress syndrome: scientific rationale. The Egyptian Heart Journal, 73(1).
Published
How to Cite
Issue
Section
Copyright (c) 2023 Kelvin Wang, Hanyu Yang; Lingfang Tang
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
